
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Clinical Infectious Diseases
Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1556048
This article is part of the Research Topic Unveiling Distinctions: Active Tuberculosis versus Latent Tuberculosis Infection - Immunological Insights, Biomarkers, and Innovative Approaches View all 4 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Latent tuberculosis infection affects about one-quarter of the global population and can progress to active tuberculosis. Hematological inflammatory markers, such as the systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio, reflect systemic inflammation and immune status but are understudied in latent tuberculosis infection. This study investigates the association between these markers and latent tuberculosis infection in a nationally representative sample.Methods: Data from 7,042 participants in the 2011-2012 National Health and Nutrition Examination Survey and transcriptomic data from the GSE19491 dataset were analyzed. Latent tuberculosis infection was identified using the QuantiFERON-TB Gold assay. Hematological parameters were measured via complete blood counts, and inflammatory markers were calculated through these parameters. Statistical analyses included linear regression adjusted for confounders and subgroup analyses. Transcriptomic analyses involved immune cell profiling, gene set enrichment, and immune checkpoint gene expression.Results: Individuals with latent tuberculosis infection had significantly lower systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-tolymphocyte ratio, and monocyte-to-lymphocyte ratio. These associations remained significant after adjusting for age, gender, body mass index, diabetes, and hypertension. Transcriptomic analyses revealed heightened activation of memory CD4 and CD8 T cells, increased cytolytic activity, and upregulated T-cell coinhibition pathways, alongside differential expression of immune checkpoint genes in individuals with latent tuberculosis infection.A lower systemic immune-inflammation index and other related hematological inflammatory markers independently correlate with latent tuberculosis infection. These findings underscore the potential significance of hematological inflammatory markers in identifying and understanding latent tuberculosis infection. Further exploration of these markers may enhance diagnostic and therapeutic strategies of tuberculosis.
Keywords: latent tuberculosis infection, Inflammation, NHANES, Transcriptome, systemic immune-inflammation index
Received: 06 Jan 2025; Accepted: 27 Feb 2025.
Copyright: © 2025 Liu, He, Zhao, Zhong, Sun, Li and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jingwei Shi, China-Japan Union Hospital, Jilin University, Changchun, 130033, Jilin Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.